CompletedPhase 3NCT02834559
Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.
Studying Vitreoretinopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Universitätsklinikum Köln
- Principal Investigator
- Friederike Schaub, PD. Dr.Department of Ophthalmology, University of Cologne
- Intervention
- 5-fluorouracil and low molecular weight heparin(drug)
- Enrollment
- 326 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2020
Study locations (13)
- Augenklinik Uniklinik Freiburg, Freiburg im Breisgau, Baden-Wurttemberg, Germany
- STZ eyetrial am Department für Augenheilkunde, Tübingen, Baden-Wurttemberg, Germany
- Klinik und Poliklinik für Augenheilkunde Uniklinik Hamburg Eppendorf, Hamburg, Hamburg, Germany
- Augenklinik Uniklinik Bonn, Bonn, North Rhine-Westphalia, Germany
- Augenklinik der Universität zu Köln, Cologne, North Rhine-Westphalia, Germany
- Universitäts-Augenklinik Düsseldorf, Düsseldorf, North Rhine-Westphalia, Germany
- Augenärzte am St. Franziskushospital Münster Augenklinik, Münster, North Rhine-Westphalia, Germany
- Knappschaftskrankenhaus Sulzbach Augenklinik Sulzbach, Sulzbach, Saarbrücken, Germany
- Uniklinik Leipzig Klinik und Poliklinik für Augenheilkunde, Leipzig, Saxony, Germany
- Universitätsaugenklinik Göttingen, Göttingen, Germany
- Universitätsaugenklinik Kiel, Kiel, Germany
- Augenklinik TU München, München, Germany
- Universitätsaugenklinik Regensburg, Regensburg, Germany
Collaborators
German Research Foundation · The Clinical Trials Centre Cologne · Pharmacy of the University Hospital Erlangen · Institute of Medical Statistics, Informatics and Epidemiology (IMSIE)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02834559 on ClinicalTrials.govOther trials for Vitreoretinopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT06033703Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal DetachmentMassachusetts Eye and Ear Infirmary
- RECRUITINGPHASE2NCT06541574Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) TrialCincinnati Eye Institute, Southwest Ohio
- RECRUITINGPHASE2NCT05523869Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative VitreoretinopathyUnity Health Toronto
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05660447A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVRWills Eye